Detalles de la búsqueda
1.
Comparing one dose of HPV vaccine in girls aged 9-14 years in Tanzania (DoRIS) with one dose in young women aged 15-20 years in Kenya (KEN SHE): an immunobridging analysis of randomised controlled trials.
Lancet Glob Health
; 12(3): e491-e499, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38365419
2.
Comparing one dose of HPV vaccine in girls aged 9-14 years in Tanzania (DoRIS) with one dose of HPV vaccine in historical cohorts: an immunobridging analysis of a randomised controlled trial.
Lancet Glob Health
; 10(10): e1485-e1493, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36113532
3.
Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trial.
Lancet Glob Health
; 10(10): e1473-e1484, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36113531
4.
Performance of International AIDS Vaccine Initiative African clinical research laboratories in standardised ELISpot and peripheral blood mononuclear cell processing in support of HIV vaccine clinical trials.
Afr J Lab Med
; 10(1): 1056, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33833946
5.
Broad HIV-1 inhibition in vitro by vaccine-elicited CD8(+) T cells in African adults.
Mol Ther Methods Clin Dev
; 3: 16061, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27617268
6.
Concordant proficiency in measurement of T-cell immunity in human immunodeficiency virus vaccine clinical trials by peripheral blood mononuclear cell and enzyme-linked immunospot assays in laboratories from three continents.
Clin Vaccine Immunol
; 16(2): 147-55, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19091991
7.
Safety and immunogenicity of recombinant low-dosage HIV-1 A vaccine candidates vectored by plasmid pTHr DNA or modified vaccinia virus Ankara (MVA) in humans in East Africa.
Vaccine
; 26(22): 2788-95, 2008 May 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-18440674
Resultados
1 -
7
de 7
1
Próxima >
>>